Patent · US Active

Sustained drug delivery system

US8642066B2 · kind B2 · utility

16Cited by
8References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 16, 2012
Grant dateFeb 4, 2014
Priority date
Expiry dateMar 4, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is a drug delivery system for delivering a drug at a sustained constant rate for a long period, which can be transplanted into an affected part safely and in a simple manner and can deliver a drug to the affected part for a long period. Specifically disclosed is a sustained drug delivery system in which an implant is implanted into a body, wherein the implant is a PEG capsule comprising a box-shaped PEG and a porous PEG sheet.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.